Welcome to the investors section of Adocia
Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.
Latest Press Releases
- 2021/09/13Number of shares and voting rights of ADOCIA as of August 31st, 2021
- 2021/09/10Adocia To Participate in the H.C. Wainwright 23rd Annual Global Investment Conference